Dr. Yuliya Knyahnytska is a Clinical Fellow with the Temerty Centre for Therapeutic Brain Stimulation at the Centre for Addiction and Mental Health (CAMH). She is also currently completing her PhD specializing in Health and Behavior Sciences at the Dalla Lana School of Public Health, University of Toronto, with a particular interest in complex and hard-to-treat illnesses. One of her main interests is is the use of innovative treatment strategies for treatment resistant mental illnesses, which includes various forms of brain stimulation interventions. Specifically her present work is dedicated to the exploration of affective symptoms and obsessive behaviors in people with treatment resistant Anorexia Nervosa with the use of novel brain stimulation intervention. If successful, this work has an enormous potential to help those who suffer from relentless and debilitating symptoms associated with the severe AN where limited number of treatment options are available up to date. Dr. Knyahnytska’s main goal is to offer innovative option to those who either did not respond, or developed severe chronic intercourse where traditional psychopharmacological and psychotherapeutic treatments failed.
Prior to coming to Toronto in 2007, she completed her medical training, and residency in psychiatry at the Bukovinian Medical University, Ukraine, where she also received her Master’s in Science with Honor (Psychiatry Division) in 2001. Acting on her interest in as broad as possible understanding of mental illnesses, and searching to expend her knowledge for variety of treatment modalities used, she has also completed her Master’s in Social Work at the University of Toronto, before moving into her PhD program in Public Health Sciences. In addition to her research, she is also actively involved in treating patients with treatment-resistant disorders, using the variety of different modalities of neurostimulaiton interventions, as well as participate in different capacities on variety of other CAMH-facilitated projects with broad focus. When not at work and is not writing her thesis, she enjoys spending time with her family, camping trips and hiking, traveling and reading.
Dr. Claire de Oliveira is a health economist and scientist at the Centre for Addiction and Mental Health (CAMH). In addition, she holds appointments at the Institute for Health Policy, Management and Evaluation at the University of Toronto and at the Institute for Clinical Evaluative Sciences. Dr. de Oliveira obtained her Masters of Arts and Doctorate degrees in economics from McMaster University. She also holds a licentiate degree in economics from the University of Oporto in Portugal.
Dr. de Oliveira’s work focuses on making the health care system more efficient and equitable. Given the need for cost containment in health care, there has been increasing interest in understanding high-cost patients and their health care utilization. This small proportion of health care users accounts for a disproportionately large share of health care costs across all care settings. Dr. de Oliveira’s program of research is examining how a specific group of high-cost patients, those with mental health and addiction problems, utilize the health care system. She uses real-word data to examine and measure health care utilization and costs among these patients to inform health policy.
Dr. de Oliveira is a board member of the Abrigo Centre and a volunteer at the Salvation Army Gateway. In her free time, she enjoys reading, attending film festivals, visiting historic house museums and traveling.
Philip Gerretsen, M.D., Ph.D., FRCPC is a clinician-scientist with the Campbell Family Mental Health Research Institute at the Centre for Addiction and Mental Health (CAMH), and the University Health Network. He is an Assistant Professor in the Department of Psychiatry, Faculty of Medicine at the University of Toronto.
Impaired illness awareness and illness denial are arguably some of the greatest barriers to the treatment of mental and medical illness. Dr. Gerretsen’s research focuses on the identification of the brain circuits of impaired illness awareness primarily through structural and functional brain imaging. The results of this research in schizophrenia have provided potential biomarkers and regional brain targets for intervention psychotherapeutically and with noninvasive neurostimulation, such as transcranial direct current and magnetic stimulation. The relevance of this work lies in the potential to alter individuals’ attitude toward their illness and treatment. This would lead ultimately to an improvement in individual’s capacity for illness recognition and engagement in treatment, which would in turn, have a significant impact on disease management.